OTCMKTS:LXXGF

LexaGene Stock Forecast, Price & News

0.27

+0.04 (+16.98%)

(As of 01/14/2022 03:59 PM ET)

Add

Compare

Today's Range: 0.21
▼
0.27
50-Day Range: 0.21
▼
0.46
52-Week Range: 0.20
▼
1.22

Volume: 367,300 shs
Average Volume: 137,900 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive LXXGF News and Ratings via Email

Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter.

About LexaGene

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated genetic analyzers for pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company is headquartered in Beverly, Massachusetts.

LexaGene Holdings Inc. (OTCMKTS:LXXGF) Short Interest Up 551.9% in December
January 15, 2022 | americanbankingnews.com

LexaGene Holdings Inc. (OTCMKTS:LXXGF) Short Interest Update
January 13, 2022 | americanbankingnews.com

LexaGene Starts the Year with Additional MiQLab Sales
January 3, 2022 | finance.yahoo.com

LexaGene Announces Results of Annual General and Special Meeting
December 17, 2021 | finance.yahoo.com

LexaGene closes multiple MiQLab sales as it makes good progress in sales cycle
December 3, 2021 | proactiveinvestors.com

LexaGene Closes Multiple MiQLab Sales
December 3, 2021 | finance.yahoo.com

LexaGene Intends to Pursue Full Panel Pathogen Testing through the FDA
November 24, 2021 | finance.yahoo.com

Leading Veterinary Academic, Dr. Jane Sykes, Joins LexaGene Board of Directors
November 15, 2021 | finance.yahoo.com

LexaGene Expands Bio-Pharma Contamination Panel by Adding Test that includes a Biothreat Agent
November 9, 2021 | finance.yahoo.com

LexaGene Receives 2021 BioTech Breakthrough Award
November 2, 2021 | finance.yahoo.com

LexaGene Finalizes Design of Pneumonia Panel
November 1, 2021 | finance.yahoo.com

LexaGene Completes First Stage of U.S. ARMY DEVCOM Agreement
October 29, 2021 | finance.yahoo.com

LexaGene’s MiQLab™ System Selected to be a Best in Show Spotlight at the 47th Annual Industry Petcare Innovation Summit
October 27, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:LXXGF
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.lexagene.com
Phone: 800 215 1824
Fax: N/A
Employees: 147,000
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for LexaGene.

0.0 Community Rank

Outperform Votes
LexaGene has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
LexaGene has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about LexaGene and other stocks. Vote “Outperform” if you believe LXXGF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LXXGF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
LexaGene does not currently pay a dividend.
Dividend Growth
LexaGene does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LexaGene insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

LexaGene (OTCMKTS:LXXGF) Frequently Asked Questions

Are investors shorting LexaGene?: LexaGene saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 33,900 shares, an increase of 551.9% from the December 15th total of 5,200 shares. Based on an average daily volume of 965,400 shares, the days-to-cover ratio is presently 0.0 days.
View LexaGene's Short Interest.
Who are LexaGene's key executives?: LexaGene's management team includes the following people:
Dr. John F. Regan, Founder, Chairman & CEO
Mr. Jeffrey Mitchell, CFO, Treasurer & Corp. Sec.
Mr. Steven Armstrong, Chief Operating Officer
Mr. Allan John Fabbro, VP of Corp. Devel. (Age 64)
Nicole Ridgedale, Director of Corp. Marketing
Jay Adelaar, VP of Capital Markets
Who are some of LexaGene's key competitors?: Some companies that are related to LexaGene include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH) and Cochlear (CHEOY).
View all of LXXGF's competitors.
What is LexaGene's stock symbol?: LexaGene trades on the OTCMKTS under the ticker symbol "LXXGF."
How do I buy shares of LexaGene?: Shares of LXXGF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is LexaGene's stock price today?: One share of LXXGF stock can currently be purchased for approximately 0.27.
How many employees does LexaGene have?: LexaGene employs 147,000 workers across the globe.
What is LexaGene's official website?: The official website for LexaGene is www.lexagene.com.
Where are LexaGene's headquarters?: LexaGene is headquartered at 500 Cummings Center, Beverly, MA 01915.
How can I contact LexaGene?: LexaGene's mailing address is 500 Cummings Center, Beverly, MA 01915. The company can be reached via phone at 800 215 1824.

This page was last updated on 1/18/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.